Target intelligence / Profile preview

RNA binding motif protein 22 pseudogene 3 (RBM22P3)

Target: RBM22P3
Molecular classification: Other (Pseudogene)

Overview

RNA binding motif protein 22 pseudogene 3 (RBM22P3) is a genomic sequence that resembles the functional RBM22 gene but lacks the ability to code for a functional protein. Pseudogenes like RBM22P3 are often byproducts of gene duplication or retrotransposition events, and while initially thought to be non-functional, recent evidence suggests they can be transcribed and may function in post-transcriptional gene regulation. For example, pseudogene transcripts may produce long non-coding RNAs that can act as microRNA sponges, regulate translation, or be processed into small RNAs (such as siRNAs or piRNAs), ultimately influencing the expression of related protein-coding genes. RBM22P3 is not recognized as a therapeutic target, nor is there evidence for direct interaction with drugs, biomarker utility, or safety considerations—its main significance is as a genomic regulatory element rather than a receptor, enzyme, or drug target.

Other names: RBM22P3RNA binding motif protein 22 pseudogene 3

Biological functions

May act as a gene regulatory element by influencing parental gene expression via non-coding RNAs, such as serving as a microRNA decoy or source for small interfering RNAs (siRNAs) and PIWI-interacting RNAs (piRNAs)

Disease associations

Indirect involvement by regulation of parental gene expression, which may theoretically impact diseases if RBM22 expression is relevant; however, there is no direct disease association for RBM22P3 specifically

Beyond the preview

Go deeper on RNA binding motif protein 22 pseudogene 3 (RBM22P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA binding motif protein 22 pseudogene 3 (RBM22P3).

Explore the full profile